Cargando…
Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge
Vestibular schwannomas (VS) expand slowly in the internal auditory canal, in the cerebellopontine angle, inside the cochlear and the labyrinth. Larger tumors can displace and compress the brainstem. With an annual incidence of 1:100,000 vestibular schwannoma represent 6–7% of all intracranial tumors...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
German Medical Science GMS Publishing House
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738934/ https://www.ncbi.nlm.nih.gov/pubmed/29279723 http://dx.doi.org/10.3205/cto000142 |
_version_ | 1783287788800573440 |
---|---|
author | Rosahl, Steffen Bohr, Christopher Lell, Michael Hamm, Klaus Iro, Heinrich |
author_facet | Rosahl, Steffen Bohr, Christopher Lell, Michael Hamm, Klaus Iro, Heinrich |
author_sort | Rosahl, Steffen |
collection | PubMed |
description | Vestibular schwannomas (VS) expand slowly in the internal auditory canal, in the cerebellopontine angle, inside the cochlear and the labyrinth. Larger tumors can displace and compress the brainstem. With an annual incidence of 1:100,000 vestibular schwannoma represent 6–7% of all intracranial tumors. In the cerebellopontine angle they are by far the most neoplasm with 90% of all lesions located in this region. Magnetic resonance imaging (MRI), audiometry, and vestibular diagnostics are the mainstays of the clinical workup for patients harboring tumors. The first part of this paper delivers an overview of tumor stages, the most common grading scales for facial nerve function and hearing as well as a short introduction to the examination of vestibular function. Upholding or improving quality of life is the central concern in counseling and treating a patient with vestibular schwannoma. Preservation of neuronal function is essential and the management options – watchful waiting, microsurgery and stereotactic radiation – should be custom-tailored to the individual situation of the patient. Continuing interdisciplinary exchange is important to monitor treatment quality and to improve treatment results. Recently, several articles and reviews have been published on the topic of vestibular schwannoma. On the occasion of the 88(th) annual meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck surgery a special volume of the journal “HNO” will be printed. Hence this presentation has been designed to deviate from the traditional standard which commonly consists of a pure literature review. The current paper was conceptually woven around a series of interdisciplinary cases that outline examples for every stage of the disease that show characteristic results for management options to date. Systematic clinical decision pathways have been deduced from our experience and from results reported in the literature. These pathways are graphically outlined after the case presentations. Important criteria for decision making are size and growth rate of the tumor, hearing of the patient and the probability of total tumor resection with preservation of hearing and facial nerve function, age and comorbidity of the patient, best possible control of vertigo and tinnitus and last but not least the patient’s preference and choice. In addition to this, the experience and the results of a given center with each treatment modality will figure in the decision making process. We will discuss findings that are reported in the literature regarding facial nerve function, hearing, vertigo, tinnitus, and headache and reflect on recent studies on their influence on the patient’s quality of life. Vertigo plays an essential role in this framework since it is an independent predictor of quality of life and a patient’s dependence on social welfare. Pathognomonic bilateral vestibular schwannomas that occur in patients suffering from neurofibromatosis typ-2 (NF2) differ from spontaneous unilateral tumors in their biologic behavior. Treatment of neurofibromatosis type-2 patients requires a multidisciplinary team, especially because of the multitude of separate intracranial and spinal lesions. Off-label chemotherapy with Bevacizumab can stabilize tumor size of vestibular schwannomas and even improve hearing over longer periods of time. Hearing rehabilitation in NF2 patients can be achieved with cochlear and auditory brainstem implants. |
format | Online Article Text |
id | pubmed-5738934 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | German Medical Science GMS Publishing House |
record_format | MEDLINE/PubMed |
spelling | pubmed-57389342017-12-26 Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge Rosahl, Steffen Bohr, Christopher Lell, Michael Hamm, Klaus Iro, Heinrich GMS Curr Top Otorhinolaryngol Head Neck Surg Article Vestibular schwannomas (VS) expand slowly in the internal auditory canal, in the cerebellopontine angle, inside the cochlear and the labyrinth. Larger tumors can displace and compress the brainstem. With an annual incidence of 1:100,000 vestibular schwannoma represent 6–7% of all intracranial tumors. In the cerebellopontine angle they are by far the most neoplasm with 90% of all lesions located in this region. Magnetic resonance imaging (MRI), audiometry, and vestibular diagnostics are the mainstays of the clinical workup for patients harboring tumors. The first part of this paper delivers an overview of tumor stages, the most common grading scales for facial nerve function and hearing as well as a short introduction to the examination of vestibular function. Upholding or improving quality of life is the central concern in counseling and treating a patient with vestibular schwannoma. Preservation of neuronal function is essential and the management options – watchful waiting, microsurgery and stereotactic radiation – should be custom-tailored to the individual situation of the patient. Continuing interdisciplinary exchange is important to monitor treatment quality and to improve treatment results. Recently, several articles and reviews have been published on the topic of vestibular schwannoma. On the occasion of the 88(th) annual meeting of the German Society of Oto-Rhino-Laryngology, Head and Neck surgery a special volume of the journal “HNO” will be printed. Hence this presentation has been designed to deviate from the traditional standard which commonly consists of a pure literature review. The current paper was conceptually woven around a series of interdisciplinary cases that outline examples for every stage of the disease that show characteristic results for management options to date. Systematic clinical decision pathways have been deduced from our experience and from results reported in the literature. These pathways are graphically outlined after the case presentations. Important criteria for decision making are size and growth rate of the tumor, hearing of the patient and the probability of total tumor resection with preservation of hearing and facial nerve function, age and comorbidity of the patient, best possible control of vertigo and tinnitus and last but not least the patient’s preference and choice. In addition to this, the experience and the results of a given center with each treatment modality will figure in the decision making process. We will discuss findings that are reported in the literature regarding facial nerve function, hearing, vertigo, tinnitus, and headache and reflect on recent studies on their influence on the patient’s quality of life. Vertigo plays an essential role in this framework since it is an independent predictor of quality of life and a patient’s dependence on social welfare. Pathognomonic bilateral vestibular schwannomas that occur in patients suffering from neurofibromatosis typ-2 (NF2) differ from spontaneous unilateral tumors in their biologic behavior. Treatment of neurofibromatosis type-2 patients requires a multidisciplinary team, especially because of the multitude of separate intracranial and spinal lesions. Off-label chemotherapy with Bevacizumab can stabilize tumor size of vestibular schwannomas and even improve hearing over longer periods of time. Hearing rehabilitation in NF2 patients can be achieved with cochlear and auditory brainstem implants. German Medical Science GMS Publishing House 2017-12-18 /pmc/articles/PMC5738934/ /pubmed/29279723 http://dx.doi.org/10.3205/cto000142 Text en Copyright © 2017 Rosahl et al. This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Rosahl, Steffen Bohr, Christopher Lell, Michael Hamm, Klaus Iro, Heinrich Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge |
title | Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge |
title_full | Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge |
title_fullStr | Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge |
title_full_unstemmed | Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge |
title_short | Diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge |
title_sort | diagnostics and therapy of vestibular schwannomas – an interdisciplinary challenge |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5738934/ https://www.ncbi.nlm.nih.gov/pubmed/29279723 http://dx.doi.org/10.3205/cto000142 |
work_keys_str_mv | AT rosahlsteffen diagnosticsandtherapyofvestibularschwannomasaninterdisciplinarychallenge AT bohrchristopher diagnosticsandtherapyofvestibularschwannomasaninterdisciplinarychallenge AT lellmichael diagnosticsandtherapyofvestibularschwannomasaninterdisciplinarychallenge AT hammklaus diagnosticsandtherapyofvestibularschwannomasaninterdisciplinarychallenge AT iroheinrich diagnosticsandtherapyofvestibularschwannomasaninterdisciplinarychallenge |